Global and China RNA-based Biopharmaceuticals Market Insights, Forecast to 2027

Table of Contents

1 Study Coverage
1.1 RNA-based Biopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global RNA-based Biopharmaceuticals Market Size Growth Rate by Type
1.2.2 Therapeutics
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global RNA-based Biopharmaceuticals Market Size Growth Rate by Application
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global RNA-based Biopharmaceuticals Market Size, Estimates and Forecasts
2.1.1 Global RNA-based Biopharmaceuticals Revenue 2016-2027
2.1.2 Global RNA-based Biopharmaceuticals Sales 2016-2027
2.2 Global RNA-based Biopharmaceuticals, Market Size by Region: 2016 VS 2021 VS 2027
2.3 RNA-based Biopharmaceuticals Historical Market Size by Region (2016-2021)
2.3.1 Global RNA-based Biopharmaceuticals Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global RNA-based Biopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 RNA-based Biopharmaceuticals Market Estimates and Projections by Region (2022-2027)
2.4.1 Global RNA-based Biopharmaceuticals Sales Forecast by Region (2022-2027)
2.4.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Region (2022-2027)

3 Global RNA-based Biopharmaceuticals Competitor Landscape by Players
3.1 Global Top RNA-based Biopharmaceuticals Manufacturers by Sales
3.1.1 Global RNA-based Biopharmaceuticals Sales by Manufacturer (2016-2021)
3.1.2 Global RNA-based Biopharmaceuticals Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top RNA-based Biopharmaceuticals Manufacturers by Revenue
3.2.1 Key RNA-based Biopharmaceuticals Manufacturers Covered: Ranking by Revenue
3.2.2 Global RNA-based Biopharmaceuticals Revenue by Manufacturers (2016-2021)
3.2.3 Global RNA-based Biopharmaceuticals Revenue Share by Manufacturers (2016-2021)
3.2.4 Global RNA-based Biopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by RNA-based Biopharmaceuticals Revenue in 2020
3.2.6 Global RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global RNA-based Biopharmaceuticals Price by Manufacturers
3.4 Global RNA-based Biopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 RNA-based Biopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers RNA-based Biopharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into RNA-based Biopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global RNA-based Biopharmaceuticals Market Size by Type (2016-2021)
4.1.1 Global RNA-based Biopharmaceuticals Sales by Type (2016-2021)
4.1.2 Global RNA-based Biopharmaceuticals Revenue by Type (2016-2021)
4.1.3 RNA-based Biopharmaceuticals Average Selling Price (ASP) by Type (2016-2021)
4.2 Global RNA-based Biopharmaceuticals Market Size Forecast by Type (2022-2027)
4.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Type (2022-2027)
4.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Type (2022-2027)
4.2.3 RNA-based Biopharmaceuticals Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global RNA-based Biopharmaceuticals Market Size by Application (2016-2021)
5.1.1 Global RNA-based Biopharmaceuticals Sales by Application (2016-2021)
5.1.2 Global RNA-based Biopharmaceuticals Revenue by Application (2016-2021)
5.1.3 RNA-based Biopharmaceuticals Price by Application (2016-2021)
5.2 RNA-based Biopharmaceuticals Market Size Forecast by Application (2022-2027)
5.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Application (2022-2027)
5.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Application (2022-2027)
5.2.3 Global RNA-based Biopharmaceuticals Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China RNA-based Biopharmaceuticals Market Size YoY Growth 2016-2027
6.1.1 China RNA-based Biopharmaceuticals Sales YoY Growth 2016-2027
6.1.2 China RNA-based Biopharmaceuticals Revenue YoY Growth 2016-2027
6.1.3 China RNA-based Biopharmaceuticals Market Share in Global Market 2016-2027
6.2 China RNA-based Biopharmaceuticals Market Size by Players (International and Local Players)
6.2.1 China Top RNA-based Biopharmaceuticals Players by Sales (2016-2021)
6.2.2 China Top RNA-based Biopharmaceuticals Players by Revenue (2016-2021)
6.3 China RNA-based Biopharmaceuticals Historic Market Review by Type (2016-2021)
6.3.1 China RNA-based Biopharmaceuticals Sales Market Share by Type (2016-2021)
6.3.2 China RNA-based Biopharmaceuticals Revenue Market Share by Type (2016-2021)
6.3.3 China RNA-based Biopharmaceuticals Price by Type (2016-2021)
6.4 China RNA-based Biopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China RNA-based Biopharmaceuticals Sales Forecast by Type (2022-2027)
6.4.2 China RNA-based Biopharmaceuticals Revenue Forecast by Type (2022-2027)
6.4.3 China RNA-based Biopharmaceuticals Price Forecast by Type (2022-2027)
6.5 China RNA-based Biopharmaceuticals Historic Market Review by Application (2016-2021)
6.5.1 China RNA-based Biopharmaceuticals Sales Market Share by Application (2016-2021)
6.5.2 China RNA-based Biopharmaceuticals Revenue Market Share by Application (2016-2021)
6.5.3 China RNA-based Biopharmaceuticals Price by Application (2016-2021)
6.6 China RNA-based Biopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China RNA-based Biopharmaceuticals Sales Forecast by Application (2022-2027)
6.6.2 China RNA-based Biopharmaceuticals Revenue Forecast by Application (2022-2027)
6.6.3 China RNA-based Biopharmaceuticals Price Forecast by Application (2022-2027)

7 North America
7.1 North America RNA-based Biopharmaceuticals Market Size YoY Growth 2016-2027
7.2 North America RNA-based Biopharmaceuticals Market Facts & Figures by Country
7.2.1 North America RNA-based Biopharmaceuticals Sales by Country (2016-2021)
7.2.2 North America RNA-based Biopharmaceuticals Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific RNA-based Biopharmaceuticals Market Size YoY Growth 2016-2027
8.2 Asia Pacific RNA-based Biopharmaceuticals Market Facts & Figures by Region
8.2.1 Asia Pacific RNA-based Biopharmaceuticals Sales by Region (2016-2021)
8.2.2 Asia Pacific RNA-based Biopharmaceuticals Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe RNA-based Biopharmaceuticals Market Size YoY Growth 2016-2027
9.2 Europe RNA-based Biopharmaceuticals Market Facts & Figures by Country
9.2.1 Europe RNA-based Biopharmaceuticals Sales by Country (2016-2021)
9.2.2 Europe RNA-based Biopharmaceuticals Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America RNA-based Biopharmaceuticals Market Size YoY Growth 2016-2027
10.2 Latin America RNA-based Biopharmaceuticals Market Facts & Figures by Country
10.2.1 Latin America RNA-based Biopharmaceuticals Sales by Country (2016-2021)
10.2.2 Latin America RNA-based Biopharmaceuticals Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa RNA-based Biopharmaceuticals Market Size YoY Growth 2016-2027
11.2 Middle East and Africa RNA-based Biopharmaceuticals Market Facts & Figures by Country
11.2.1 Middle East and Africa RNA-based Biopharmaceuticals Sales by Country (2016-2021)
11.2.2 Middle East and Africa RNA-based Biopharmaceuticals Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer RNA-based Biopharmaceuticals Products Offered
12.1.5 Pfizer Recent Development
12.2 Roche
12.2.1 Roche Corporation Information
12.2.2 Roche Description and Business Overview
12.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Roche RNA-based Biopharmaceuticals Products Offered
12.2.5 Roche Recent Development
12.3 Sanofi-Aventis
12.3.1 Sanofi-Aventis Corporation Information
12.3.2 Sanofi-Aventis Description and Business Overview
12.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Products Offered
12.3.5 Sanofi-Aventis Recent Development
12.4 Abbott Laboratories
12.4.1 Abbott Laboratories Corporation Information
12.4.2 Abbott Laboratories Description and Business Overview
12.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Products Offered
12.4.5 Abbott Laboratories Recent Development
12.5 Arrowhead Pharmaceuticals
12.5.1 Arrowhead Pharmaceuticals Corporation Information
12.5.2 Arrowhead Pharmaceuticals Description and Business Overview
12.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Products Offered
12.5.5 Arrowhead Pharmaceuticals Recent Development
12.6 Benitec Biopharma
12.6.1 Benitec Biopharma Corporation Information
12.6.2 Benitec Biopharma Description and Business Overview
12.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Products Offered
12.6.5 Benitec Biopharma Recent Development
12.7 Calimmune Inc
12.7.1 Calimmune Inc Corporation Information
12.7.2 Calimmune Inc Description and Business Overview
12.7.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Calimmune Inc RNA-based Biopharmaceuticals Products Offered
12.7.5 Calimmune Inc Recent Development
12.8 Dicerna
12.8.1 Dicerna Corporation Information
12.8.2 Dicerna Description and Business Overview
12.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Dicerna RNA-based Biopharmaceuticals Products Offered
12.8.5 Dicerna Recent Development
12.9 Gradalis
12.9.1 Gradalis Corporation Information
12.9.2 Gradalis Description and Business Overview
12.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Gradalis RNA-based Biopharmaceuticals Products Offered
12.9.5 Gradalis Recent Development
12.10 Quark
12.10.1 Quark Corporation Information
12.10.2 Quark Description and Business Overview
12.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Quark RNA-based Biopharmaceuticals Products Offered
12.10.5 Quark Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer RNA-based Biopharmaceuticals Products Offered
12.11.5 Pfizer Recent Development
12.12 Senesco
12.12.1 Senesco Corporation Information
12.12.2 Senesco Description and Business Overview
12.12.3 Senesco RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Senesco Products Offered
12.12.5 Senesco Recent Development
12.13 Silence Therapeutics
12.13.1 Silence Therapeutics Corporation Information
12.13.2 Silence Therapeutics Description and Business Overview
12.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Silence Therapeutics Products Offered
12.13.5 Silence Therapeutics Recent Development
12.14 Silenseed
12.14.1 Silenseed Corporation Information
12.14.2 Silenseed Description and Business Overview
12.14.3 Silenseed RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Silenseed Products Offered
12.14.5 Silenseed Recent Development
12.15 Tekmira
12.15.1 Tekmira Corporation Information
12.15.2 Tekmira Description and Business Overview
12.15.3 Tekmira RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Tekmira Products Offered
12.15.5 Tekmira Recent Development
12.16 Alnylam Pharmaceuticals
12.16.1 Alnylam Pharmaceuticals Corporation Information
12.16.2 Alnylam Pharmaceuticals Description and Business Overview
12.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Alnylam Pharmaceuticals Products Offered
12.16.5 Alnylam Pharmaceuticals Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 RNA-based Biopharmaceuticals Industry Trends
13.2 RNA-based Biopharmaceuticals Market Drivers
13.3 RNA-based Biopharmaceuticals Market Challenges
13.4 RNA-based Biopharmaceuticals Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 RNA-based Biopharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global RNA-based Biopharmaceuticals Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Therapeutics
Table 3. Major Manufacturers of Vaccines
Table 4. Global RNA-based Biopharmaceuticals Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global RNA-based Biopharmaceuticals Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global RNA-based Biopharmaceuticals Sales by Regions (2016-2021) & (K Units)
Table 7. Global RNA-based Biopharmaceuticals Sales Market Share by Regions (2016-2021)
Table 8. Global RNA-based Biopharmaceuticals Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global RNA-based Biopharmaceuticals Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 11. Global RNA-based Biopharmaceuticals Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global RNA-based Biopharmaceuticals Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global RNA-based Biopharmaceuticals Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top RNA-based Biopharmaceuticals Manufacturers by Revenue (US$ Million) in 2020
Table 16. RNA-based Biopharmaceuticals Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. RNA-based Biopharmaceuticals Revenue Share by Manufacturers (2016-2021)
Table 18. Global RNA-based Biopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global RNA-based Biopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA-based Biopharmaceuticals as of 2020)
Table 20. Key Manufacturers RNA-based Biopharmaceuticals Price (2016-2021) (USD/Unit)
Table 21. RNA-based Biopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers RNA-based Biopharmaceuticals Product Type
Table 23. Date of International Manufacturers Enter into RNA-based Biopharmaceuticals Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA-based Biopharmaceuticals Sales by Type (2016-2021) (K Units)
Table 26. Global RNA-based Biopharmaceuticals Sales Share by Type (2016-2021)
Table 27. Global RNA-based Biopharmaceuticals Revenue by Type (2016-2021) (US$ Million)
Table 28. Global RNA-based Biopharmaceuticals Revenue Share by Type (2016-2021)
Table 29. RNA-based Biopharmaceuticals Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global RNA-based Biopharmaceuticals Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Type (2022-2027)
Table 32. Global RNA-based Biopharmaceuticals Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global RNA-based Biopharmaceuticals Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global RNA-based Biopharmaceuticals Sales by Application (2016-2021) (K Units)
Table 36. Global RNA-based Biopharmaceuticals Sales Share by Application (2016-2021)
Table 37. Global RNA-based Biopharmaceuticals Revenue by Application (2016-2021) (US$ Million)
Table 38. Global RNA-based Biopharmaceuticals Revenue Share by Application (2016-2021)
Table 39. RNA-based Biopharmaceuticals Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global RNA-based Biopharmaceuticals Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Application (2022-2027)
Table 42. Global RNA-based Biopharmaceuticals Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global RNA-based Biopharmaceuticals Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. China RNA-based Biopharmaceuticals Sales (K Units) of Key Companies (2016-2021)
Table 46. China RNA-based Biopharmaceuticals Sales Share by Company (2016-2021)
Table 47. China RNA-based Biopharmaceuticals Revenue (US$ Million) by Company (2016-2021)
Table 48. China RNA-based Biopharmaceuticals Revenue Share by Company (2016-2021)
Table 49. China RNA-based Biopharmaceuticals Sales (K Units) by Type (2016-2021)
Table 50. China RNA-based Biopharmaceuticals Sales Share by Type (2016-2021)
Table 51. China RNA-based Biopharmaceuticals Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China RNA-based Biopharmaceuticals Price (USD/Unit) by Type (2016-2021)
Table 53. China RNA-based Biopharmaceuticals Sales (K Units) by Type (2022-2027)
Table 54. China RNA-based Biopharmaceuticals Sales Share by Type (2022-2027)
Table 55. China RNA-based Biopharmaceuticals Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China RNA-based Biopharmaceuticals Revenue Share by Type (2022-2027)
Table 57. China RNA-based Biopharmaceuticals Price (USD/Unit) by Type (2022-2027)
Table 58. China RNA-based Biopharmaceuticals Sales (K Units) by Application (2016-2021)
Table 59. China RNA-based Biopharmaceuticals Sales Share by Application (2016-2021)
Table 60. China RNA-based Biopharmaceuticals Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China RNA-based Biopharmaceuticals Price (USD/Unit) by Application (2016-2021)
Table 62. China RNA-based Biopharmaceuticals Sales (K Units) by Application (2022-2027)
Table 63. China RNA-based Biopharmaceuticals Sales Share by Application (2022-2027)
Table 64. China RNA-based Biopharmaceuticals Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China RNA-based Biopharmaceuticals Revenue Share by Application (2022-2027)
Table 66. China RNA-based Biopharmaceuticals Price (USD/Unit) by Application (2022-2027)
Table 67. North America RNA-based Biopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 68. North America RNA-based Biopharmaceuticals Sales Market Share by Country (2016-2021)
Table 69. North America RNA-based Biopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America RNA-based Biopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific RNA-based Biopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific RNA-based Biopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific RNA-based Biopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 75. Europe RNA-based Biopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 76. Europe RNA-based Biopharmaceuticals Sales Market Share by Country (2016-2021)
Table 77. Europe RNA-based Biopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe RNA-based Biopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 79. Latin America RNA-based Biopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 80. Latin America RNA-based Biopharmaceuticals Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa RNA-based Biopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America RNA-based Biopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa RNA-based Biopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa RNA-based Biopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa RNA-based Biopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 87. Pfizer Corporation Information
Table 88. Pfizer Description and Business Overview
Table 89. Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. Pfizer RNA-based Biopharmaceuticals Product
Table 91. Pfizer Recent Development
Table 92. Roche Corporation Information
Table 93. Roche Description and Business Overview
Table 94. Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Roche Product
Table 96. Roche Recent Development
Table 97. Sanofi-Aventis Corporation Information
Table 98. Sanofi-Aventis Description and Business Overview
Table 99. Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. Sanofi-Aventis Product
Table 101. Sanofi-Aventis Recent Development
Table 102. Abbott Laboratories Corporation Information
Table 103. Abbott Laboratories Description and Business Overview
Table 104. Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Abbott Laboratories Product
Table 106. Abbott Laboratories Recent Development
Table 107. Arrowhead Pharmaceuticals Corporation Information
Table 108. Arrowhead Pharmaceuticals Description and Business Overview
Table 109. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Arrowhead Pharmaceuticals Product
Table 111. Arrowhead Pharmaceuticals Recent Development
Table 112. Benitec Biopharma Corporation Information
Table 113. Benitec Biopharma Description and Business Overview
Table 114. Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Benitec Biopharma Product
Table 116. Benitec Biopharma Recent Development
Table 117. Calimmune Inc Corporation Information
Table 118. Calimmune Inc Description and Business Overview
Table 119. Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Calimmune Inc Product
Table 121. Calimmune Inc Recent Development
Table 122. Dicerna Corporation Information
Table 123. Dicerna Description and Business Overview
Table 124. Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Dicerna Product
Table 126. Dicerna Recent Development
Table 127. Gradalis Corporation Information
Table 128. Gradalis Description and Business Overview
Table 129. Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Gradalis Product
Table 131. Gradalis Recent Development
Table 132. Quark Corporation Information
Table 133. Quark Description and Business Overview
Table 134. Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. Quark Product
Table 136. Quark Recent Development
Table 137. RXi Corporation Information
Table 138. RXi Description and Business Overview
Table 139. RXi RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. RXi Product
Table 141. RXi Recent Development
Table 142. Senesco Corporation Information
Table 143. Senesco Description and Business Overview
Table 144. Senesco RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. Senesco Product
Table 146. Senesco Recent Development
Table 147. Silence Therapeutics Corporation Information
Table 148. Silence Therapeutics Description and Business Overview
Table 149. Silence Therapeutics RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 150. Silence Therapeutics Product
Table 151. Silence Therapeutics Recent Development
Table 152. Silenseed Corporation Information
Table 153. Silenseed Description and Business Overview
Table 154. Silenseed RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 155. Silenseed Product
Table 156. Silenseed Recent Development
Table 157. Tekmira Corporation Information
Table 158. Tekmira Description and Business Overview
Table 159. Tekmira RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 160. Tekmira Product
Table 161. Tekmira Recent Development
Table 162. Alnylam Pharmaceuticals Corporation Information
Table 163. Alnylam Pharmaceuticals Description and Business Overview
Table 164. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 165. Alnylam Pharmaceuticals Product
Table 166. Alnylam Pharmaceuticals Recent Development
Table 167. RNA-based Biopharmaceuticals Market Trends
Table 168. RNA-based Biopharmaceuticals Market Drivers
Table 169. RNA-based Biopharmaceuticals Market Challenges
Table 170. RNA-based Biopharmaceuticals Market Restraints
Table 171. RNA-based Biopharmaceuticals Customers List
Table 172. RNA-based Biopharmaceuticals Distributors List
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA-based Biopharmaceuticals Product Picture
Figure 2. Global RNA-based Biopharmaceuticals Sales Market Share by Type in 2020 & 2027
Figure 3. Therapeutics Product Picture
Figure 4. Vaccines Product Picture
Figure 5. Global RNA-based Biopharmaceuticals Sales Market Share by Application in 2020 & 2027
Figure 6. Cancer
Figure 7. Diabetes
Figure 8. Tuberculosis
Figure 9. Cardiovascular Diseases
Figure 10. Others
Figure 11. RNA-based Biopharmaceuticals Report Years Considered
Figure 12. Global RNA-based Biopharmaceuticals Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global RNA-based Biopharmaceuticals Market Size 2016-2027 (US$ Million)
Figure 14. Global RNA-based Biopharmaceuticals Sales 2016-2027 (K Units)
Figure 15. Global RNA-based Biopharmaceuticals Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global RNA-based Biopharmaceuticals Sales Market Share by Region (2016-2021)
Figure 17. Global RNA-based Biopharmaceuticals Sales Market Share by Region in 2020
Figure 18. Global RNA-based Biopharmaceuticals Revenue Market Share by Region (2016-2021)
Figure 19. Global RNA-based Biopharmaceuticals Revenue Market Share by Region in 2020
Figure 20. Global RNA-based Biopharmaceuticals Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by RNA-based Biopharmaceuticals Revenue in 2020
Figure 22. RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global RNA-based Biopharmaceuticals Sales Market Share by Type (2016-2021)
Figure 24. Global RNA-based Biopharmaceuticals Sales Market Share by Type in 2020
Figure 25. Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2016-2021)
Figure 26. Global RNA-based Biopharmaceuticals Revenue Market Share by Type in 2020
Figure 27. Global RNA-based Biopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 28. Global RNA-based Biopharmaceuticals Sales Market Share by Application in 2020
Figure 29. Global RNA-based Biopharmaceuticals Revenue Market Share by Application (2016-2021)
Figure 30. Global RNA-based Biopharmaceuticals Revenue Market Share by Application in 2020
Figure 31. China RNA-based Biopharmaceuticals Sales Growth Rate 2016-2027 (K Units)
Figure 32. China RNA-based Biopharmaceuticals Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China RNA-based Biopharmaceuticals Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest RNA-based Biopharmaceuticals Players Market Share by Revenue in RNA-based Biopharmaceuticals in 2020
Figure 35. China RNA-based Biopharmaceuticals Revenue Share by Type (2016-2021)
Figure 36. China RNA-based Biopharmaceuticals Revenue Growth Rate b